GSN and dementia: In contrast to research by Güntert et al. reporting no significant changes in brain gelsolin levels between dementia patients and non-AD patients [142], Ji et al. demonstrated decreased gelsolin levels and increased 48 kDa carboxyl-terminal fragments (gelsolin-CTF) in the frontal cortex of individuals.